Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial. de Padua Souza C, Carneiro ASB, de Oliveira Lessa AC, Lacerda DC, et al. Breast Cancer Res Treat 2023 Aug 14. doi: 10.1007/s10549-023-07011.

Read + Share

Amedeo Smart

Independent Medical Education

de Padua Souza C, Carneiro ASB, de Oliveira Lessa AC, Lacerda DC, et al. Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial. Breast Cancer Res Treat 2023 Aug 14. doi: 10.1007/s10549-023-07011.
PMID: 37578666